Opportunity
DIBBS #SPE2DP-26-T-3932
DLA Procurement of Moxifloxacin Hydrochloride Tablets for USS Mustin
Posted
June 30, 2026
Respond By
July 06, 2026
Identifier
SPE2DP-26-T-3932
NAICS
424210
The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain Pharm FSA is procuring Moxifloxacin Hydrochloride Tablets for delivery to the USS Mustin DDG 89. - Government Buyer: - Defense Logistics Agency (DLA) - Sub-agency: DLA Troop Support Medical Supply Chain Pharm FSA - OEMs and Vendors: - TEVA PHARMACEUTICALS USA, INC. - RISING PHARMA HOLDINGS, INC. - Products Requested: - Moxifloxacin Hydrochloride Tablets, 400 mg, 30 tablets per bottle - National Stock Number (NSN): 6505-01-503-4772 - Part numbers: NDC00093-7387-56 (TEVA), NDC57237-0156-30 (RISING PHARMA) - Quantity: 12 bottles - Notable Requirements: - Delivery required within 5 days, FOB destination to USS Mustin DDG 89 - Product must be FDA regulated - Packaging and labeling must comply with DLA medical marking standard no. 1 - Compliance with Buy American Act and hazardous material labeling - Only products from approved sources (TEVA and RISING PHARMA) are accepted
Description
MOXIFLOXACIN HYDROCHLO (QTY: 12, NSN: 6505-01-503-4772, Purchase Request: 7017319340) Approved Sources: - CAGE: 3V8D7, Part No: NDC00093-7387-56, Company: TEVA PHARMACEUTICALS USA, INC. - CAGE: 8FG82, Part No: NDC57237-0156-30, Company: RISING PHARMA HOLDINGS, INC.